The 11-cis-retinylidene chromophore of visual pigments isomerizes upon interaction with a photon, initiating a downstream cascade of signaling events that ultimately lead to visual perception. 11-cis-Retinylidene is regenerated through enzymatic transformations collectively called the visual cycle. The first and rate-limiting enzymatic reaction within this cycle, i.e., the reduction of all-trans-retinal to all-trans-retinol, is catalyzed by retinol dehydrogenases. Here, we determined the structure of Drosophila melanogaster photoreceptor retinol dehydrogenase (PDH) isoform C that belongs to the short-chain dehydrogenase/reductase (SDR) family. This is the first reported structure of a SDR that possesses this biologically important activity. Two crystal structures of the same enzyme grown under different conditions revealed a novel conformational change of the NAD + cofactor, likely representing a change during catalysis. Amide hydrogen−deuterium exchange of PDH demonstrated changes in the structure of the enzyme upon dinucleotide binding. In D. melanogaster, loss of PDH activity leads to photoreceptor degeneration that can be partially rescued by transgenic expression of human RDH12. Based on the structure of PDH, we analyzed mutations causing Leber congenital amaurosis 13 in a homology model of human RDH12 to obtain insights into the molecular basis of RDH12 disease-causing mutations. O ne of the key reactions involved in vitamin A metabolism and in recycling of the chromophore in vision is the NAD(P)-dependent reversible redox reaction of retinol/retinal catalyzed by alcohol dehydrogenases.
O ne of the key reactions involved in vitamin A metabolism and in recycling of the chromophore in vision is the NAD(P)-dependent reversible redox reaction of retinol/retinal catalyzed by alcohol dehydrogenases.
1−3 A subclass of enzymes from the SDR superfamily appears to have evolved specifically to catalyze the retinol dehydrogenase reaction. 4−8 In invertebrate photoreceptors, all-trans-retinylidene remains bound to opsin in a stably photoactivated form and a second photon of light is required to convert it back to 11-cis-3-hydroxy-retinal. 4,9−13 In flies, the chromophore is required for rhodopsin maturation, and the free chromophore can induce photoreceptor degeneration when opsin is lacking. 14 However, there is recent evidence of some enzymatic turnover of the chromophore. A mutation was discovered in a gene encoding a pigment cell-enriched NAD-dependent SDR, namely Drosophila melanogaster photoreceptor cell dehydrogenase (PDH) , that leads to light-dependent degeneration of photoreceptor cells. Light responses and rhodopsin levels were normal in young pdh-deficient flies or in old mutant flies maintained in the dark. 4 However, under a light/dark cycle, pdh-deficient flies underwent photoreceptor degeneration with a progressive loss of retinoids and a concomitant loss of rhodopsin. Notably, this phenotype was partially rescued by ectopic expression of human RDH12 (NP_689656.2). These findings suggest that an enzymatic chromophore regeneration pathway (visual cycle) is required in flies for maintaining rhodopsin levels and the health of photoreceptors. 4, 11, 12 In vertebrate vision, these redox reactions are enzymatically facilitated by retinol dehydrogenases with geometric (cis/trans) isomeric mono or dual specificities, such as RDH5, RDH8, RDH10, RDH11, and RDH12.
1 Mutations in these enzymes lead to either mild (RDH5 and RDH11) or severe (RDH12) impairments of vision or can even be lethal (RDH10) because of the requirement of retinoic acid during embryonic development. 15−21 As an example, mutations of the RDH12 gene result in severe visual dystrophies, such as LCA13 or retinitis pigmentosa 53 (RP 53). 21 Unfortunately, no structural studies have been performed on the vertebrate enzymes, because of the inherent difficulty in expressing and purifying these proteins. Therefore, we turned to an invertebrate retinol dehydrogenase, PDH.
Here, we present information about the crystal structure of D. melanogaster PDH. To the best of our knowledge, it is the first structure of a retinol dehydrogenase from the SDR family. Structural data obtained through crystallization in the presence of β-ionone suggest a novel binary conformation state of the cofactor NAD + prior to binding of the substrate. 22−24 Our findings also support the proposal that enzymatic activity relies on the dimerization of the protein as observed for other SDRs. 25 A model of functionally related RDH12 allowed prediction of the impact of disease-causing mutations within the catalytic domain, including the dinucleotide-binding site of the protein or the dimerization interface.
■ MATERIALS AND METHODS
Protein Expression and Purification. D. melanogaster pdh-c (NM_001144487.2) was cloned in a pet-45b(+) vector and expressed in BL21 Escherichia coli. The integrity of this expression plasmid was confirmed by sequencing. The plasmid was transformed into E. coli strain BL21 (DE3) (New England Biolabs, Ipswich, MA) for protein expression studies. One liter LB medium cultures containing 100 mg of ampicillin were grown at 37°C to an OD 600 of 0.6−0.9, after which the temperature was decreased to 25°C and cultures were induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside. After growing for 6 h, cells were harvested by centrifugation and stored at −80°C. Bacterial cells were lysed by four subsequent passages through a French press at 20000 psi. The lysis buffer consisted of 50 mM Tris (pH 8.0), 500 mM NaCl, and 20% glycerol. The lysate was centrifuged for 30 min at 10000g. The supernatant was filtered through a 0.22 μm Millex GS filter unit (Millipore, Carrigtwohill, Ireland). The filtrate was loaded onto a nickel column (cOplete His tag purification resin, Roche Diagnostic Corp., Indianapolis, IN) in the presence of 5 mM imidazole, followed by a washing step with 50 mM imidazole until no change in absorbance at 280 nm was detected. Protein then was eluted with 20 mM HEPES (pH 7.0), 500 mM NaCl, and 300 mM imidazole. The eluent was loaded onto a Sephacryl S300 HR column (GE Healthcare) equilibrated with 20 mM HEPES (pH 7.0), 680 mM NaCl, and 0.1 mM DDT. Peak fractions were combined and concentrated to 2.5 mg of protein/mL. Protein samples (≥95% pure as judged by sodium dodecyl sulfate−polyacrylamide gel electrophoresis) were placed on ice for immediate use.
Protein Crystallization, Structural Determination, and Analyses. PDHc (NP_001137959.1) was crystallized by the sitting-drop vapor-diffusion method at 4°C in the presence of 1 mM NAD or NADH. One microliter of purified enzyme at 2.5 mg/mL in 20 mM HEPES (pH 7.0) containing 10% (w/v) glycerol and 1 mM dinucleotide was mixed with a reservoir solution containing 0.1 M BisTris (pH 6.5), 25% (w/v) PEG 3350, and either 10 mM phenol or 10 mM β-ionone in a 1:1 ratio. Cubic-or triangular-shaped crystals typically appeared within 3 days in both cases. Mature crystals were harvested, swished through a reservoir mixture containing 15% glycerol, and flash-cooled in liquid nitrogen before being exposed to Xrays. 26 Diffraction data were collected at the NE-CAT 24-ID-E beamline of the Advanced Proton Source. These data were indexed, integrated, and scaled with the XDS package. 27 The structures were determined by molecular replacement in Phaser using Protein Data Bank (PDB) entry 1B2L as the starting model. 22, 28, 29 Manual adjustments to each structure were made with COOT, and restrained refinement was performed in REFMAC5 and phenix.refine. 30−33 Structures were validated with MOLPROBITY and the wwPDB structure validation server. 34, 35 A summary of the X-ray data and refinement statistics is shown in Table S1 . Structural figures were prepared with PyMOL or Discovery Studio Visualizer. 36, 37 Omit maps for the ligands were calculated with phenix.maps in the absence of ligands in the model file and with the initial mtz reflection file.
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Activity Assay of PDH Crystals. Oxidation of all-transretinol in PDH crystals was assayed by monitoring the production of all-trans-retinal in the presence of NAD + . 24, 39 The oxidation mixture added to the crystallization drop contained 1 mM NAD + , 0.1 M phosphate buffer (pH 8.0), 680 mM NaCl, 10% PEG 200, 20% PEG 3350, and 244 μM alltrans-retinol. Reduction of all-trans-retinal in PDH crystals was assayed with 1 mM NADH, 0.1 M phosphate buffer (pH 5.0), 680 mM NaCl, 10% PEG 200, 20% PEG 3350, and 431 μM alltrans-retinal. For each redox reaction, 96 crystallization drops were incubated for 2 h at room temperature before they were harvested. The control was conducted in crystallization drops without protein. The reaction was quenched with 100 μL of methanol, and retinoids were extracted twice with 200 μL of hexane. Retinoids were separated by normal phase highperformance liquid chromatography (HPLC) in 90% hexane and 10% ethyl acetate and analyzed at both 325 and 360 nm. The reduction of 3-hydroxy-retinal followed the same procedure as described above for all-trans-retinal. 3-Hydroxyretinoids were obtained by enzymatically converting zeaxanthin with insect β,β-carotenoid-15,15′-oxygenase (called NINAB). Analysis and separation of 3-hydroxy-retinoids were accomplished by normal phase HPLC in 70% hexane and 30% ethyl acetate and analyzed at 325 nm. All steps were conducted under dim red light. Enzymatic activity was also tested with PDH precipitated without formation of crystals by 25% PEG 3350 and 0.1 M BTP (pH 6.5), added to the purified protein in a reaction solution of 10% PEG 200 and 20% PEG 3350 in 0.1 M BTP (pH 6.5). No activity was observed in the precipitated PDH under identical reaction conditions as observed in the redox reaction for PDH in its crystalline state.
Extensive experiments were performed to verify the catalytic activity of PDH in solution. We tested retinol dehydrogenase activity under the following conditions, all of which were analyzed with retinal, retinol, and 3-hydroxy-retinal: in the presence of CHAPS or DDM detergent micelles; in the presence of CHAPS or DDM detergent micelles with bovine albumin; in the presence of bovine albumin alone; in the presence of synthetic liposomes in which the lipid composition mimicked that of the bovine photoreceptor disc membranes, namely, 44% PE, 44% PC, and 44% PS by mass; all four isoforms [ 40−42 EPPIC classifies protein−protein interactions in a crystal lattice by including multiple-sequence alignments of homologues with ≥60% sequence identity. This classification is based on a geometric measure, namely the number of core residues and two evolutionary indicators derived from the sequence entropy of homologue sequences. Both aim to detect differential selection pressure between the interface core and either the rim or the remainder of the surface. 40 The protein−protein interaction of heterologous PDH was assessed with fast protein liquid chromatography (FPLC). PDH was analyzed either in the presence of 1 mM NAD + and 1 mM NADH or without dinucleotide on a Superdex 200 increase column (GE Healthcare, Pittsburgh, PA) using the equilibration buffer described in the purification protocol.
Differential Scanning Fluorimetry (DSF). Protein stability was assessed by DSF as previously reported. 43 Briefly, the protein was diluted to a concentration of 6 μM and screened in the presence of 2 μM reporter dye, BODIPY FL Lcystine. Fifteen microliters of sample plus dye were screened against 5 μL of Hampton additive screen HT (Hampton Research, Aliso Viejo, CA). The melting temperature was determined with a Boltzmann fit. The K d for NAD + was determined with DSF measurements. 43 Briefly, the melting temperature of the protein−ligand complex was determined in triplicate with a 2-fold dilution series from 18.75 to 0.009 mM NAD + . Melting curves were fitted to the Boltzmann equation, and the resulting melting temperatures were analyzed with SigmaPlot version 11.0 according to a standard ligand binding curve. 44 Energy Calculations. Gaussian09 software was used for quantum chemical calculations. 45 A two-layer ONIOM model 46 was employed for calculations of the protein−NAD complex, with the NAD molecule treated at the Hartree−Fock theory level with 3-21 g basis sets. 47−52 The AMBER molecular mechanics force field 53 was used for the protein. The complex was geometrically optimized, and the total ONIOM energy is reported, as well as the energy for just NAD within the complex. To obtain the energy of the two conformations of NAD in solution, the molecule was extracted from the optimized complex structures. A single-point energy calculation was then performed at the Hartree−Fock theory level with 3-21 g basis sets and water as the solvent using the polarizable continuum model.
54−70
Amide Hydrogen−Deuterium Exchange of PDH. Amide hydrogen−deuterium exchange was performed as follows. Approximately 0.8 μg of purified PDH was diluted in 45 μL of D 2 O containing 20 mM HEPES (pH 7.0) and kept on ice for 5, 10, 15, 20, or 25 min. After exposure to deuterated buffer, the exchange was terminated with ice cold quenching buffer composed of D 2 O and 20 mM HEPES (pH 7.0). Ten microliters of pepsin (8.0 mg/mL, Worthington, Lakewood, NJ) was immediately added to the solution, and the sample was digested for 15 min on ice. Next, the sample (100 μL) was loaded onto a Luna 20 mm × 2.00 mm C18 column (Phenomenex, Torrance, CA) with a temperature-controlled Hewlett-Packard autosampler set to 4°C. Peptides were eluted with the following gradient sequence: from 0 to 4 min, 98% H 2 O with 0.1% (v/v) formic acid (A) and 2% acetonitrile with 0.1% (v/v) formic acid (B); from 4 to 12 min, 98 to 2% A. Separation was performed with an Agilent 1100 HPLC system (Agilent Technologies, Santa Clara, CA) at a flow rate of 0.2 mL/min. The eluent was injected into a Thermo Finnigan LXQ (Thermo Scientific, Waltham, MA) MS instrument equipped with an electrospray ionization source operated in a positive ion mode with other parameters adjusted as follows: activation type set to collision-induced dissociation, normalized collision energy to 35 kV, capillary temperature to 370°C, source voltage to 5 kV, capillary voltage to 43 V, tube lens to 105 V, and MS spectra were collected over a range of m/z 200−2000. To avoid sample propagation from one HPLC run to another, each production run was followed by a mock injection of 10 μL of solution A with a resulting HPLC elution profile identical to the one described above. This run was followed by a 20 min equilibration run with 98% A and 2% B for 20 min. Experiments were performed at least in triplicate for each time point.
Analysis of Hydrogen−Deuterium Exchange. Peptides resulting from the pepsin digestion were identified by MS/MS by employing the online version of MassMatrix. 71 Search settings used to examine a peptic digest were as follows: precursor ion tolerance, 0.8 Da; maximal number of variable modifications allowed for each peptide sequence, 2; minimal peptide length, 4 amino acids; minimal pp score, 5; pptag score, 1.3; maximal number of combinations of different modification sites for a peptide match with modifications, 1; and maximal number of candidate peptide matches for each spectrum output in the result, 1. 72 Peptides reproducibly identified in 2 were used to construct the progress plots. Raw data in the form of relative signal intensity (percent) as a function of m/z were extracted with XCalibur 2.1.0. Qual Browser was used for a recently described semiautomated peak detection and deconvolution procedure performed with HDExpress software. 73, 74 Briefly, after deuterium uptake was evaluated with the raw data, the value for every peptide fragment was normalized to 75% of the theoretically maximal exchangeable sites to account for the 75% deuteration accomplished experimentally (Table S2 , column 4). For calculations of the maximal number of exchangeable sites, only peptide bonds were used to account for amide exchange; deuterium exchange from side chains was considered negligible and thus was not included. The maximal number of exchangeable sites was decreased by one for each P residue in a peptide sequence. Hydrogen−deuterium exchange was color-coded on the basis of the total percent of the theoretical maximal deuterium uptake at 10 min as follows: blue, 10−19%; violet, 20−29%; cyan, 30−39%; green, 40−49%; yellow, 50−59%; and orange, 60−69%.
RDH12 Modeling. The RDH12 model was calculated on the basis of the PDH crystal structure template from the SWISS-MODEL Workspace. 75−77 This model (32.48 sequence identity) yielded a GMQE value of 0.6 and a QMEAN4 of −9.66. stereospecificity but did not produce information that could be used for structural biology approaches. 7, 8, 78, 79 In fact, no structure of a retinol dehydrogenase from the SDR family has yet been reported. Because the pdh-c mutant can be rescued with the RDH12 knock-in in D. melanogaster, we focused on this invertebrate enzyme. 4, 11, 12 The structure of PDH in the presence of NAD + and phenol was determined by molecular replacement using PDB entry 1B2L. PDH crystallized in the dimeric state with a Rossman fold typical of SDRs ( Figure 1A−C) . 22,80−83 Furthermore, the three-dimensional structure closely resembled (RMSD = 1.35 Å) that of the alcohol dehydrogenase from Drosophila lebanonensis (PDB entry 1B2L). The surface of the cofactorbinding site in the presence of phenol had a funnel-like shape (Figure 1 ). The NAD + entrance at the top of the funnel was characterized by hydrophilic patches, whereas the bottom entry site for the substrate was entirely hydrophobic and identically located in each monomer ( Figure 1B,C) . This arrangement allows a membrane-residing substrate, such as retinaldehyde, to have access to the enzyme's catalytically active site ( Figure  1B,C) . The C-termini of both monomers overlapped and collapsed on each other ( Figure 1C ). The increased B-factor noted for the C-terminus (Figures S1 and S2) and results of previous research regarding membrane association of the Cand N-termini of SDRs indicate that the C-terminal conformation reported here is a crystallographic artifact. 84−87 The dissociation constant (K d ) for NAD + binding from DSF yielded a value of 170 ± 30 μM ( Figure S3) . 43 This value agrees with published K d values for other members of the SDR family. 88, 89 The ligand interaction diagram based on the structure is shown in Figure 1D .
Dimerization of short-and medium-chain dehydrogenases is a prerequisite for their activity. 25 (Table S3) . 41 Furthermore, evolutionary analysis of the protein−protein interface with Evolutionary Protein−protein Interface Classifier (EPPIC) supported data calculated by PISA that classified the interface as being of biological origin ( Figure  2 and Table S4) . 40 Residues contributing to the dimer interface are depicted as sticks (Figure 2 ) and were evaluated with EPPIC (Table S5) . 40 Gel filtration analysis of heterologous PDH in the presence or absence of dinucleotide revealed a monomeric mass under both conditions. The theoretical molecular weight (MW) determined with the ExPASy server was 29453 Da. 96 The MW of the apo state PDH as determined by gel filtration was 30.3 kDa. In the presence of NAD + , the MW was 27.1 kDa, and in the presence of NADH, the MW was 25.6 kDa. These masses provide evidence of a monomeric form of PDH expressed in E. coli, as previously reported for other SDRs. 95, 97 Here, the presence of a cofactor resulted in a lower molecular weight, which can be explained by a more compact structure and thus a reduced hydrodynamic radius that delayed elution from the gel filtration column. Additionally, the oligomeric state of PDH was analyzed by determining its MW upon gel filtration at four protein concentrations ranging from 20 to 0.5 mg/mL. The MWs of PDH indicated a sole monomeric species at all protein concentrations (Figure 2 ).
Purified and heterologously expressed PDH from E. coli or Sf9 insect cells at various concentrations was enzymatically inactive. Therefore, we assessed the activity of PDH in a crystalline state, where concentrations of the protein are significantly higher. As reported above, PDH was found in a dimeric state within crystals but not in solution. Indeed, it has been reported that SDRs remain catalytically active in a crystallized form. 24, 39 Enzymatic redox reactions were per- formed in the crystallization drops along with the suitable cofactor. Figure 3 reveals an analysis of the reaction products by HPLC. The reduction of all-trans-retinal to all-trans-retinol is shown in Figure 3A with the corresponding spectra. Oxidation of all-trans-retinol to all-trans-retinal is depicted in Figure 3B . The naturally occurring substrate of D. melanogaster PDH is 3-hydroxy-retinal. Therefore, the enzymatic activity of PDH crystals was verified in the presence of this compound ( Figure  S4A ). Accordingly, extraction and analysis of the retinoid composition from D. melanogaster fly heads revealed a significant reduction in the levels of both 11-cis-and all-trans-3-hydroxy-retinal in pdh 1 mutants ( Figure S4B ). As reported previously, the Ser-Tyr-Lys catalytic triad of SDRs is extended by a proton relay system. 82,95,98−101 Sitedirected mutagenesis emphasized the importance of this catalytic triad for SDR enzymatic activity. 102 Among these three residues, Tyr is the most conserved among different family members. Panels A and B of Figure 4 show the catalytic triad Ser137-Tyr150-Lys154 of PDH in the presence of phenol ( Figure 4A ) and PDH crystallized in the presence of β-ionone ( Figure 4B ). Distances between the cofactor and the catalytic triad consistent with hydrogen bonds are depicted with dashed lines. Also, a σ−π interaction between Tyr150 and Lys154 is highlighted by an orange dashed line. The reactive hydride atom (yellow) of NADH was modeled on the basis of the NAD + structure used for crystallization. Cofactor isomerization as an integral characteristic of the aldehyde dehydrogenase family has been the topic of several investigations. 39, 103, 104 From extensive fluorescence measurements, a Mg 2+ -and substrate-dependent cofactor isomerization reaction mechanism was proposed. 88, 105 However, to date, there is no structural evidence of cofactor isomerization in the same SDR enzyme. Here, we showed an alternative binary state of NAD + complexed in a SDR (Figure 4B,D; PDB entry 5ILO). The conformation of the cofactor in both structures was confirmed with omit maps ( Figure S5) . A comparison of panels C and D of Figure 4 revealed a hydrogen bond between Ser137 and the amide group of NAD + . This interaction was not seen in the structure when phenol was present ( Figure 4C , PDB entry 5ILG). Instead, Ser137 was within hydrogen bonding distance of phenol ( Figure 4A ). As seen in human aldehyde dehydrogenases, isomerization resulted in the alternative configuration of the cofactor (Figure 4 and Figure S5 ).
Calculations indicated an energetically favored binary complex conformation of the NAD(H) cofactor as found in PDB entry 5ILO (Table S6 ). The binary complex conformation of NAD(H) found there is ∼27.24 kJ/mol more favorable than that of the ternary complex conformation in 5ILG. The energetics of NAD(H) in vacuum and water supported previous analyses. NAD(H) in 5ILO is approximately 49.23 and 51.63 kJ/mol more stable than the conformation found in 5ILG in vacuum and water, respectively. Thus, an energetically favored binary state is accommodated by the cofactor prior to substrate binding. Once the substrate binds, the nicotinamide group "flips" to its accessible conformation (Figures 4 and 5) . Moreover, we calculated the energies for each conformation in the presence and absence of the protein (Table S6 ). These data also support a nicotinamide flip (5ILO → 5ILG) upon substrate binding ( Figure 5 ).
Hydrogen/deuterium exchange studies of PDH in the presence and absence of NAD + provided insights into the stabilization of the protein upon cofactor binding (Figure 6 ). The β-sheets within the Rossmann fold were stabilized by cofactor binding as was the loop between β-sheets 5 and 6. However, the extensive loop that connects β-sheets 6 and 7 exhibited higher flexibility. The flexibility and dynamics of the loop region between β-sheets of the Rossmann fold were in agreement with the B-factors calculated from the crystal structures (5ILG and 5ILO) ( Figures S1 and S2) . Figure S1 represents the B-factors of 5ILG in which the increased thermal motion of the loop between β-sheets 6 and 7 agreed with the increased flexibility shown with hydrogen/deuterium exchange and is consistent with gel filtration experiments that showed a decrease in the volume of the enzyme. The largest RMSD values between 5ILG and 5ILO were found in the loop region and the α-helical portion of PDH ( Figure S2 ). Larger RMSD values between 5ILO and 5ILG were found in places where the B-factors of both structures also were elevated ( Figure S2 ).
As indicated in the introduction, RDH12 is the human functional orthologue of PDH that reduces all-trans-retinal to all-trans-retinol in a NADP(H)-dependent manner. 7 The RDH12 model was generated with the SWISS-MODEL server based on the PDH (5ILG) crystal structure 75−77 as depicted in Figure 7 . Disease-causing mutations derived from the OMIM database are listed in Table S7 . (Tables S4  and S5) . 40 The gel filtration analysis (bottom) was performed with the Gel Filtration Standard (model 151-1901) from Bio-Rad. Standards were thyroglobulin (bovine) (670 kDa), γ-globulin (bovine) (158 kDa), ovalbumin (chicken) (44 kDa), myoglobin (horse) (17 kDa), and vitamin B12 (1.35 kDa). PDH was injected both without (red) and with (violet) the dinucleotide NAD + or NADH (green). Concentration-dependent oligomerization was analyzed at PDH concentrations ranging from 20 to 0.5 mg/mL.
■ DISCUSSION
PDH provides the first structural study of a crystallized retinol dehydrogenase from the SDR family. For the first time, we obtained structural evidence of a cofactor binary state of PDH that differs from published structures of non-retinoid SDRs. Structural data combined with energy calculations indicated that the cofactor NAD(H) undergoes a conformational change upon binding of the substrate to these enzymes. Thus, isomerization of NAD(H) takes place prior to substrate binding and cofactor release. Isomerization of NAD(H) was reported previously in the context of cofactor release, 88,105−108 but such data were derived from fluorescence lifetime measurements and NMR studies of aldehyde dehydrogenase 1 (ALDH1), a member of the medium-chain dehydrogenase/ reductase (MDRs) family. 109 Real-time measurements of NADH fluorescence suggested that three different species of NADH exist, namely, free NADH and two bound species of NADH with shorter and longer fluorescence lifetimes. 88, 105 The species with the longer fluorescence lifetime (accessible state, 5ILG) is produced through isomerization and is dependent on substrate concentration. 88, 108 On the basis of the energy calculations of 5ILG and 5ILO and the corresponding NAD(H) conformation, we conclude that the structure found in 5ILO represents the binary state of this enzyme in the absence of substrate. Thus, the amide group of the cofactor interacts via a hydrogen bridge with Ser137. Once the substrate approaches, the nicotinamide group undergoes a flip to its accessible conformation (5ILG) in which the hydride is within hydrogen bonding distance of the substrate (Figures 4 and 6) . This mechanism is supported by enzymatic analyses of other dehydrogenases. 108, 110 DHRS4 (NP_001269916.1) and DHRS10 (NP_057330.2) are human SDRs that are dependent on NADP(H) and NAD(H), respectively. Both SDRs are known to reduce or oxidize 3-ketosteroids or 3β-hydroxy-steroids. 111−113 Figure S6 presents an alignment of the crystal structures of DHRS4 (red), DHRS10 (green), and PDH (yellow). The cofactor-binding site common to all SDR family members is nearly identical (low luminance). This finding is further supported by the low RMSD values between these structures (e.g., 1.58 Å for DHRS4 vs PDH, 1.07 Å for DHRS10 vs PDH, and 0.95 Å for DHRS4 vs DHRS10). Major differences in these structures were found only within two loop regions (high luminance) located at the substrate-binding site. The loop between β-sheets 4 and 5 showed a shortened connection in the PDH crystal structure. Moreover, the loop between β-sheets 6 and 7 revealed a completely rearranged structure as compared to the DHRS structures. This loop region also is associated with the substrate-binding site. 22 The substrate-binding loop region in PDH interacted with the opposite loop between β-sheets 5 and 6 via a hydrogen bond network and highly structured waters (S7, S17, and S20 in 5ILG). The interaction between these two opposite site loops strongly favors a substrate-binding site distant from the hydrophobic opening as depicted in Figure  1A −C.
Enzymatic assays with PDH were performed in the crystalline state in which PDH existed in a dimeric conformation. However, in solution, PDH was found exclusively in a monomeric form (Figure 2 ). The lack of activity in solution could thus be explained by the monomeric state of not only PDH but also other SDRs. The dependence of activity on the oligomeric state of a SDR was previously investigated by site-directed mutagenesis. 25 Results from that study agree with our data indicating that a monomeric SDR is inactive. Furthermore, this finding explains the underlying molecular mechanism of disease-causing mutations located near the dimer interface of RDH12 (Figure 7) . The importance of dimerization for the activity of SDRs offers a specific target for drugs to regulate the activity of any given SDR. 25 We made an interesting observation related to the enzymatic activity of PDH. First, the previously developed assay was validated by using bovine rod outer segment membranes that expressed high levels of retinol dehydrogenase activity. 114 This assay relies on direct detection of the retinol or retinal product, but no activity was detected in the various experimental settings described in Materials and Methods, including insect cell expression systems. This lack of activity could not be attributed to a nonproductive conformation of protein but rather to a major conformational change because the polypeptide fold is very similar to other known SDRs. When the protein was precipitated with PEG to form an amorphous material, no activity was detected either. Only when crystals were present were the enzymatic products observed. As demonstrated biochemically, PDH is monomeric even at a concentration of 20 mg/mL, but in a crystal, the dehydrogenase is present in the dimeric form where its concentration was calculated from the Matthews volume to be 826 mg/mL. For most SDRs, the dimer is obligatory for enzymatic activity, 25 but to the best of our knowledge, neither the monomeric nor the dimeric structures of the same enzyme are known. The most straightforward interpretation of these phenomena is that monomeric PDH is inactive and that dimerization brings together sites that then become active. Such catalytically competent dimers could have a slightly differently arranged side chain induced by dimerization. PDH crystallizes under a very narrow range of conditions, and we failed to obtain crystals in a different space group where PDH existed in a monomeric state. In insect eyes, expression of PDH could require an anchor protein that further stabilizes the dimeric form. Indeed, as demonstrated previously and here by retinoid analyses, PDH is biologically active in vivo.
SDRs in general have very similar folds. Now with the results of the retinol dehydrogenase structure, it is clear that there is nothing unusual about this subclass of enzymes. Thus, we can now generate models across different RDHs with greater confidence. Moreover, the interface of the PDH identified here provides additional insights. Of particular interest are those RDHs associated with human retinal diseases such as severe LCA caused by mutations in RDH12. Of the 16 listed mutations for RDH12, two cause retinitis pigmentosa 53 and 14 induce LCA 13.
115 RP 53 mutations (776delG and Ala126Val) result in a mild and late onset variant of retinitis pigmentosa. 19 These mutations are shown as balls and sticks in Figure 7 . Most mutations underlying LCA were found at sites that interact with the cofactor or directly with the catalytic triad Table S7 . Mutations distant from the cofactor-binding site are highlighted with a yellow background (Tyr226Cys and Thr155Ile). Mutations interacting with the cofactor or substrate-binding site are highlighted with a blue background. RDH12 is colored according to its secondary structural elements; β-sheets are colored cyan, helices red, and loops green. (Table S7 ). These results suggest that inactivation or decreased activity of the enzyme could cause this disease. Two mutations, Tyr226Cys and Thr155Ile located near the dimer interface, are known to cause LCA 13. Further progress in expressing RDH12 will be needed to validate this supposition for the last two mutations.
■ SUMMARY
Mutations in retinol dehydrogenases from the SDR family are associated with a broad spectrum of ocular diseases. We provide structural insights into the biochemical functioning of this class of enzymes by determining the structure of a D. melanogaster photoreceptor dehydrogenase, PDH. Comparisons of two structures with phenol and β-ionone suggest a potential substrate-induced conformational change of the cofactor NAD(H) during catalysis. Our enzymatic analyses of PDH strongly favor a native dimeric state. It was suggested that substrate binding in D. melanogaster alcohol dehydrogenase occurs at virtually the same cytosolic site as cofactor binding. 22 Although this could be true for soluble and hydrophilic substrates, we propose that binding of hydrophobic substrates such as retinoids occurs at the opposite site. Our finding is supported by data regarding the potential membrane-spanning N-terminus in some SDRs. 84, 85, 116 Hence, in a dimeric state that is crucial for the activity of PDH, the substrate entry faces the membrane, as suggested in Figure 1B . Therefore, we propose a "kiss-and-run" mechanism for the redox reactions of hydrophobic substrates that eliminates thermodynamically unfavorable extraction of retinoid from the phospholipid fraction by allowing the substrate to partially reside within the membrane. Moreover, the molecular basis of diseasecausing mutations associated with severe impairments in human vision also was suggested by comparing the D. melanogaster dehydrogenase with its functionally related human orthologue, RDH12.
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